Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 8 studies | 31% ± 11% | |
glutamatergic neuron | 7 studies | 30% ± 16% | |
pericyte | 7 studies | 17% ± 2% | |
plasmacytoid dendritic cell | 7 studies | 27% ± 12% | |
endothelial cell | 6 studies | 19% ± 3% | |
astrocyte | 6 studies | 27% ± 12% | |
macrophage | 5 studies | 17% ± 1% | |
fibroblast | 4 studies | 28% ± 13% | |
type I pneumocyte | 3 studies | 23% ± 3% | |
classical monocyte | 3 studies | 18% ± 2% | |
epithelial cell | 3 studies | 28% ± 5% | |
interneuron | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 36% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2084.20 | 180 / 180 | 100% | 25.04 | 430 / 430 |
esophagus | 100% | 1404.94 | 1445 / 1445 | 99% | 33.09 | 181 / 183 |
thymus | 100% | 875.37 | 652 / 653 | 99% | 24.55 | 598 / 605 |
lung | 100% | 1189.16 | 577 / 578 | 98% | 32.67 | 1132 / 1155 |
intestine | 100% | 1182.89 | 966 / 966 | 98% | 12.73 | 515 / 527 |
bladder | 100% | 1624.81 | 21 / 21 | 98% | 23.41 | 492 / 504 |
stomach | 100% | 908.74 | 359 / 359 | 97% | 15.09 | 278 / 286 |
uterus | 100% | 1432.72 | 170 / 170 | 97% | 34.33 | 446 / 459 |
brain | 100% | 1338.90 | 2638 / 2642 | 97% | 13.35 | 686 / 705 |
prostate | 100% | 1008.01 | 244 / 245 | 97% | 13.93 | 485 / 502 |
breast | 100% | 996.75 | 458 / 459 | 93% | 15.79 | 1044 / 1118 |
kidney | 97% | 481.45 | 86 / 89 | 89% | 15.18 | 801 / 901 |
skin | 100% | 1337.00 | 1806 / 1809 | 81% | 8.17 | 380 / 472 |
liver | 100% | 1013.38 | 225 / 226 | 80% | 12.51 | 326 / 406 |
pancreas | 82% | 321.69 | 270 / 328 | 97% | 14.98 | 172 / 178 |
adrenal gland | 98% | 693.11 | 254 / 258 | 80% | 8.83 | 184 / 230 |
blood vessel | 100% | 1807.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 907.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.18 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.26 | 1 / 1 |
adipose | 100% | 1155.01 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 653.56 | 819 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 9.87 | 24 / 29 |
muscle | 79% | 307.78 | 638 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 617.57 | 711 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 6.51 | 47 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051896 | Biological process | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0060038 | Biological process | cardiac muscle cell proliferation |
GO_0034392 | Biological process | negative regulation of smooth muscle cell apoptotic process |
GO_1900020 | Biological process | positive regulation of protein kinase C activity |
GO_0005615 | Cellular component | extracellular space |
GO_0000139 | Cellular component | Golgi membrane |
GO_0030126 | Cellular component | COPI vesicle coat |
Gene name | DIPK2A |
Protein name | Divergent protein kinase domain 2A Divergent protein kinase domain 2A (Deleted in autism protein 1) (Golgi Protein of 49 kDa) (GoPro49) (Hypoxia and AKT-induced stem cell factor) (HASF) |
Synonyms | C3orf58 DIA1 |
Description | FUNCTION: May play a role in cardiomyocyte proliferation through paracrine signaling and activation of the PPI3K-AKT-CDK7 signaling cascade. . |
Accessions | ENST00000495414.5 [Q8NDZ4-2] ENST00000315691.8 [Q8NDZ4-1] E7ET39 Q8NDZ4 ENST00000492452.2 C9JY09 ENST00000441925.2 |